Southern Copper Corporation (NYSE:SCCO)
Southern Copper Corporation (NYSE:SCCO) represented a move of -0.18 percent or $-0.14 per share and closed its previous day trading session at $33.48. 761560 Shares were traded in the last trading session with an Average Volume of 1.01 Million Shares. The stock currently has a Market Capitalization of 25.93 Billion.
Southern Copper Corporation is a mining metallurgical company, producer of copper and valuable by-products.
The stock traded between $31.17 and $58.09 over 1-Year time period showing its price to sales ratio of 3.57. Southern Copper Corporation (NYSE:SCCO) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-14.91 and 200-Day Simple Moving Average of $-28.55. Its Price to Free Cash Flow is 69.27 and Price to Book of 3.93.
Analyst’s recommended the stock as 3.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Southern Copper Corporation (NYSE:SCCO) reported its Actual EPS of $0.48/share. The analysts offering Earnings Estimates for the company were believing that Southern Copper Corporation could bring EPS of $0.5/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -4 Percent.
MacroGenics, Inc. (NASDAQ:MGNX)
In the last trading session, MacroGenics, Inc. (NASDAQ:MGNX) added its value by 2.75% closing at the price of $17.21. The stock currently has market capitalization of 707.85 Million, with average volume of 273.05 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently MacroGenics, Inc. (NASDAQ:MGNX) is showing beta of 2.53. This particular value of beta suggests that MacroGenics, Inc. (NASDAQ:MGNX) has historically moved 253% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for MacroGenics, Inc. (NASDAQ:MGNX) is at $-0.3.
The stock currently has RSI of 47.64. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.
MacroGenics, Inc. (NASDAQ:MGNX) topped its 52-week high price of $32.74 on 03/08/18 and 52-Week Low Price of $15.48 on 10/31/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 5.73% and monthly volatility of 6.06% respectively.